1. GBM skin metastasis: a case report and review of the literature
   Gary D Lewis et al, 2017, CNS Oncology CrossRef
2. Antitumor activity of rhein lysinate against human glioma U87 cells in vitro and in vivo
   JIN LIU et al, 2016, Oncology Reports CrossRef
3. Receptor-Targeted Glial Brain Tumor Therapies
   Puja Sharma et al, 2018, International Journal of Molecular Sciences CrossRef
4. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
   Vildan B. Cetintas et al, 2020, Journal of Translational Medicine CrossRef
5. High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma
   Jin-feng Zhang et al, 2016, Human Pathology CrossRef
6. In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas
   Vasiliki Galani et al, 2017, Journal of Interferon & Cytokine Research CrossRef
7. JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
   null null et al, 2018, Journal of Neuro-Oncology CrossRef
8. Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone
   null null et al, 2020, Journal of Neuro-Oncology CrossRef
9. Spatiotemporal combination of thermosensitive polypeptide fused interferon and temozolomide for post-surgical glioblastoma immunochemotherapy
   Ping Liang et al, 2021, Biomaterials CrossRef
10. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas
    Chengcheng Guo et al, 2023, JAMA Network Open CrossRef
11. The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway
    Laura Martin-Hijano et al, 2020, Frontiers in Immunology CrossRef